The global development agenda is shifting. There were three health goals in the 8 Millennium Development Goals that served as a guiding priority framework for the past 15 years. Fighting HIV, TB and malaria was one of these goals. But post-2015, the world is embracing 17 proposed Sustainable Development Goals, and health is only one of them. Coupled with the growing resource needs to sustain HIV programmes and the flat-lining of external financing for the...read full post
The many breakthroughs in HIV have not been matched with the shift in financing perspective that is required by a disease with chronic as well as infectious characteristics, with the attendant financial and ethical burden that this entails.read full post
RethinkHIV is a consortium of senior researchers from London School of Hygiene & Tropical Medicine, Imperial College London, Harvard School of Public Health, Centre for the Study of African Economies and Blavatnik School of Government at Oxford University.
The consortium will evaluate new evidence related to the costs, benefits, effects, fiscal implications, and developmental impacts of HIV interventions in sub-Saharan Africa, in order to maximise contributions to the fight against HIV there.
The aim of RethinkHIV is to find ways of creating, optimising, and sustaining fiscal space for domestic HIV investment, as well as exploring long-term, sustainable national and international financing mechanisms. RethinkHIV is funded by RUSH Foundation.